AN2 Therapeutics Inc (NASDAQ:ANTX)
| 15.00 Delayed Data As of Nov 28 |  -1.42 / -8.65%Today’s Change | 4.87 Today|||52-Week Range 17.75 | +57.40% Year-to-Date |
Latest ANTX News | Press Releases
No recent news for AN2 Therapeutics Inc.
Today’s Trading
| Previous close | 16.42 |
| Today’s open | 15.90 |
| Day’s range | 14.29 - 15.90 |
| Volume | 6,863 |
| Average volume (3 months) | 54,750 |
| Market cap | $484.2M |
Data as of 3:59pm ET, 11/28/2023
Growth & Valuation
| Earnings growth (last year) | -47.25% |
| Earnings growth (this year) | -28.14% |
| Earnings growth (next 5 years) | +14.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 3.31 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | March 27, 2024 |
| EPS forecast (this quarter) | -$1.00 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$41.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
